Treatment of Progressive MS: Why, Who, When, How
Giancarlo Comi, MD
More Than “Women’s Issues": Women’s Reproductive and Gynaecological Health and Work
SPECIAL REPORT: Expert Opinion on New MS Drug Approval
Prof. Ralf Gold
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Reducing the Burden of MS Treatment
Benefit/Risk Strategies in Selecting Therapeutic Solutions for MS
Establishing Partnerships to Optimize Patient Outcomes
Immunologic Effects on Metabolic Syndrome and MS
Optimizing MS Treatment Options
Highlights from the MAGNIMS Consensus Guidelines
Current and Future MS Treatment Options
Determining an MS Patient's Long-Term Prognosis
Early Diagnosis/Long-Term Prognosis of MS - Dr. Jiwon Oh
Current Landscape of MS Diagnosis/Prognosis
Emerging MRI Techniques in MS Patients
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.